Correlation of hematologic parameters with bone marrow and spleen uptake in FDG PET;Correlación de los parámetros hematológicos con la captación de FDG en médula ósea y bazo en la PET

Revista Espanola de Medicina Nuclear

Volumn 24, Issue 2, 2005, Pages 107-112

  Nunez R ^a,b   Rini, J N ^a   Tronco, G G ^a   Tomas, M B ^a   Nichols, K ^a   Palestro, C J ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bone marrow and spleen; FDG PET; Hematologic parameters

Indexed keywords

FLUORODEOXYGLUCOSE; HEMOGLOBIN;

ARTICLE; BONE MARROW; CALCULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; HEMATOLOGICAL PARAMETERS; HODGKIN DISEASE; HUMAN; LEUKOCYTE; LIVER; LUNG; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; SPINE; SPLEEN; THROMBOCYTE COUNT;

EID: 16244382059     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13071686     Document Type: Article

References (22)

1. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-48.
2. Moog F, Bangerter M, Kotzerker J, Guhlmann A, Frickhofen N, Reske S. 18-F-fluorodeoxiglucose-positron emissin tomography as a new approach to detect lymphomatous bone marrow. J Nucl Med 1995;36:794-9.
3. Carr R, Barrington S, Madan B, O'Doherty MJ, Saunders CAB, Van der Walt J, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 1998;91:3340-6.
4. Kato T, Tsukamoto E, Nishioka T, Yamazaki A, Shirato H, Kobayashi S, et al. Early detection of bone marrow involvement in extramedullary plasmocytoma by whole-body F-18 FDG positron emission tomography. Clin Nucl Med 2000;25:870-3.
5. Rini J, Leonidas JC, Tomas MB, Palestro CJ. F18-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 2003;44:1072-4.
6. Hamilton JA, Vairo G, Lingelbach SR. Activation and proliferation signals in murine macrophages: stimulation of glucose uptake by hematopoietic growth factors and other agents. J Cell Physiol 1998;134:405-12.
7. Wahl RL, Fisher SJ. FDG uptake into normal bone marrow is markedly increased by colony stimulating factors G-CSF and GM-CSF. J Nucl Med 1993;34:245P.
8. Hamilton JA, Vairo G, Lingelbach SR. CSF-1 stimulates glucose uptake in murine bone marrow-derived macrophages. Biochem Biophys Res Commun 1986;138:445-54.
9. Iversen PO, Nicolaysen G, Benestad HB. The leukopoietic cytokine granulocyte colony-stimulating factor increases blood flow to rat bone marrow. Exp. Hematol 1993;21:231-5.
10. Yao WJ, Hoh C, Hawkins RA, Glapsy JA, Weil JA, Lee SJ, et al. Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines. J Nucl Med 1994;36:794-9.
11. 18 Positron Emission Tomography. Ann Pharmacother 2002;36:1796-9.
12. Knopp MV, Bishoff H, Rimac A, Oberdorfer F, van Kaick G. Bone marrow uptake of fluorine-18-fluorodeoxiglucose following treatment with hematopoietic growth factors: initial evaluation 1996 Nucl Med Biol 1996;23:845-9.
13. Hollinger EF, Alibazoglu H, Ali A, Green A, Lamonica G. Hematopoietic cytokine mediated FDG uptake stimulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med 1997;23:93-8.
14. Sugawara Y, Fisher SJ, Zasadny KR, Kison PV, Baker LH, Wahl R. Preclinical and clinical studies of bone marrow uptake of fluorine-18- fluorodeoxiglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol 1998;16:173-80.
15. Gundlapalli S, Ojha B, Mountz JM. Granulocyte colony-stimulating factor: confounding F-18 FDG uptake in outpatient positron emission tomographic facilities for patients receiving ongoing treatment of lymphoma. Clin Nucl Med 2002;24:141-2.
16. Ruiz-Hernández G, Scaglione C, Delgado-Bolton RC, Gutiérrez-García A, Madero L, Jiménez-Vicioso A, Carreras-Delgado JL. Hipercaptación esplénica secundaria a factor estimulador de colonias granulocitarias (G-CSF) en el estudio PET-FDG. Rev Esp Med Nucl 2004;23:124-6.
17. Kunze WD, Baehre M, Richter E. PET with dual-head coincidence camera: spatial resolution, scatter fraction and sensitivity. J Nucl Med 2000;41:1067-74.
18. Reske SN. Recent advances in bone marrow scanning. Eur J Nucl Med 1991;18:203-21.
19. Shpall EJ, Gee AP, Hogan C, et al. Bone marrow metastases. Hematol Oncol Clin North Am 1996;10:321-43.
20. Abdel-Dayem HM, Sanchez J, Al-Mohannadi S, Kempf J. Diffuse Thallium-201-chloride uptake in hypermetabolic bone marrow following treatment with granulocyte stimulating factor. J Nucl Med 1992;33:2014-6.
21. Plantade A, Montravers F, Selle F, Izrael V, Talbot JN. Diffusely Increased F-18 FDG Uptake in Bone Marrow in a Patient With Acute Anemia and Recent Erythropoietin Therapy. Clin Nucl Med 2003;28:771-2.
22. Chiang SB, Rebenstock A, Guan L, Alavi A, Zhuang H. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine_mediated FDG uptake on FDG PET imaging. Clin Nucl Med 2003;28:674-6.